bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Figure S3A from Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer
Authors: Janni Wolfgang J. , Rack Brigitte , Terstappen Leon W.M.M. , Pierga Jean-Yves , Taran Florin-Andrei , Fehm Tanja , Hall Carolyn , de Groot Marco R. , Bidard François-Clement , Friedl Thomas W.P. , Fasching Peter A. , Brucker Sara Y. , Pantel Klaus , Lucci Anthony
Published: April 2023

Figure S3. Kaplan-Meier plots of overall survival according to the presence of circulating tumor cells at the time of primary breast cancer diagnosis. Panel A shows the predefined low-risk (T1/N0) patient subgroup, and Panel B shows the high-risk (T234/N123) patient subgroup.
Supplementary Table S3. from Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus
Authors: Jenkinson Claire , Elliott Victoria L. , Evans Anthony , Oldfield Lucy , Jenkins Rosalind E. , O'Brien Darragh P. , Apostolidou Sophia , Gentry-Maharaj Aleksandra , Fourkala Evangelia-O , Jacobs Ian J. , Menon Usha , Cox Trevor , Campbell Fiona , Pereira Stephen P. , Tuveson David A. , Park B. Kevin , Greenhalf William , Sutton Robert , Timms John F. , Neoptolemos John P. , Costello Eithne
Published: April 2023

Representative data from the T5600 iTRAQ serum 8-plex experiment. iTRAQ labels were used as follows: 113: 0-6m cases, 114: 0-6m controls, 115: 6-12m cases, 116: 6-12m controls, 117: PDAC non obstructed, 118: PDAC obstructed, 119: CP, 121: HC (PBRU) (all samples relative to 121 - HC).
Supplementary Figure S3. from Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus
Authors: Jenkinson Claire , Elliott Victoria L. , Evans Anthony , Oldfield Lucy , Jenkins Rosalind E. , O'Brien Darragh P. , Apostolidou Sophia , Gentry-Maharaj Aleksandra , Fourkala Evangelia-O , Jacobs Ian J. , Menon Usha , Cox Trevor , Campbell Fiona , Pereira Stephen P. , Tuveson David A. , Park B. Kevin , Greenhalf William , Sutton Robert , Timms John F. , Neoptolemos John P. , Costello Eithne
Published: April 2023

Detection of CA1-9 by ELISA in (A) individual time to diagnosis groups and (B) diagnosed samples and controls.
Supplementary Table S2 from Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma
Authors: Ekmekcioglu Suhendan , Davies Michael A. , Tanese Keiji , Roszik Jason , Shin-Sim Myung , Bassett Roland L. , Milton Denái R. , Woodman Scott E. , Prieto Victor G. , Gershenwald Jeffrey E. , Morton Donald L. , Hoon Dave S. , Grimm Elizabeth A.
Published: April 2023

This table contains multivariable Cox Analyses on survival models in validation set
SUPPLEMENTARY DATA from Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus
Authors: Jenkinson Claire , Elliott Victoria L. , Evans Anthony , Oldfield Lucy , Jenkins Rosalind E. , O'Brien Darragh P. , Apostolidou Sophia , Gentry-Maharaj Aleksandra , Fourkala Evangelia-O , Jacobs Ian J. , Menon Usha , Cox Trevor , Campbell Fiona , Pereira Stephen P. , Tuveson David A. , Park B. Kevin , Greenhalf William , Sutton Robert , Timms John F. , Neoptolemos John P. , Costello Eithne
Published: April 2023

Supplementary Legends
Supplemantary Figure S2 from Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma
Authors: Ekmekcioglu Suhendan , Davies Michael A. , Tanese Keiji , Roszik Jason , Shin-Sim Myung , Bassett Roland L. , Milton Denái R. , Woodman Scott E. , Prieto Victor G. , Gershenwald Jeffrey E. , Morton Donald L. , Hoon Dave S. , Grimm Elizabeth A.
Published: April 2023

Clinical outcomes by CD74 categorical expression (both number and intensity) in tumor cells (A) in discovery and (B) in validation datasets of stage III melanoma patients. Kaplan-Meier analyses are shown for OS and RFS.
Supplemental Information from Pericytes Promote Malignant Ovarian Cancer Progression in Mice and Predict Poor Prognosis in Serous Ovarian Cancer Patients
Authors: Sinha Devbarna , Chong Lynn , George Joshy , Schlüter Holger , Mönchgesang Susann , Mills Stuart , Li Jason , Parish Christopher , Bowtell David , Kaur Pritinder
Published: April 2023

Supplemental Figures 1-6, Supplemental Tables 1-2, Supplemental Materials & Methods, Supplemental References Figure S1. Increased tumour growth is not a result of decreased apoptosis. Figure S2. Pericytes increase OVCAR-5 cell proliferation in vitro. Figure S3. Pericytes promote metastasis in vivo. Figure S4. Pericytes promote growth and initiate metastasis in the non-metastatic OVCAR-8 cells in vivo. Figure S5. Pericytes recruit αSMAcells expressing BM-MSC markers to OVCAR-5 xenografts. Figure S6. CD34 and PDGFRβ expression do not correlate with early relapse in serous ovarian cancer patients. Table S1: List of probe sets for the 146 overlapping genes up-regulated in both the pericytes and ovarian stroma. Table S2A-D: Top GO cellular component, molecular function & biological processes terms; and KEGG pathways enriched in early versus late relapse patients. Supplemental Methods: Details of methods used for in silico analyses, GFP transduction of cells, immunostaining, invasion assays and morphometric analyses.
Supplementary Table S7 from Identification and Functional Validation of Reciprocal microRNA–mRNA Pairings in African American Prostate Cancer Disparities
Authors: Wang Bi-Dar , Ceniccola Kristin , Yang Qi , Andrawis Ramez , Patel Vyomesh , Ji Youngmi , Rhim Johng , Olender Jacqueline , Popratiloff Anastas , Latham Patricia , Lai Yinglei , Patierno Steven R. , Lee Norman H.
Published: April 2023

Supplementary Table S7. Significant pathways identified by Global test in A) AA PCa vs. EA PCa, B) AA PCa vs AA NP, and C) EA PCa vs EA NP
Supplementary Table S6 from Identification and Functional Validation of Reciprocal microRNA–mRNA Pairings in African American Prostate Cancer Disparities
Authors: Wang Bi-Dar , Ceniccola Kristin , Yang Qi , Andrawis Ramez , Patel Vyomesh , Ji Youngmi , Rhim Johng , Olender Jacqueline , Popratiloff Anastas , Latham Patricia , Lai Yinglei , Patierno Steven R. , Lee Norman H.
Published: April 2023

Supplementary Table S6. miRNA-mRNA pairings in A) AA PCa vs. EA PCa, B) AA PCa vs AA NP, and C) EA PCa vs EA NP
Table S1 from Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS
Authors: Yoshitake Yoshihiro , Fukuma Daiki , Yuno Akira , Hirayama Masatoshi , Nakayama Hideki , Tanaka Takuya , Nagata Masashi , Takamune Yasuo , Kawahara Kenta , Nakagawa Yoshihiro , Yoshida Ryoji , Hirosue Akiyuki , Ogi Hidenao , Hiraki Akimitsu , Jono Hirofumi , Hamada Akinobu , Yoshida Koji , Nishimura Yasuharu , Nakamura Yusuke , Shinohara Masanori
Published: April 2023

Table S1. Patient background
Figure S3 from Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS
Authors: Yoshitake Yoshihiro , Fukuma Daiki , Yuno Akira , Hirayama Masatoshi , Nakayama Hideki , Tanaka Takuya , Nagata Masashi , Takamune Yasuo , Kawahara Kenta , Nakagawa Yoshihiro , Yoshida Ryoji , Hirosue Akiyuki , Ogi Hidenao , Hiraki Akimitsu , Jono Hirofumi , Hamada Akinobu , Yoshida Koji , Nishimura Yasuharu , Nakamura Yusuke , Shinohara Masanori
Published: April 2023

Figure S3. Analysis of the frequency of Treg cells in the 5 vaccinated patients.
Supplemental Table 2 from Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non–Small Cell Lung Cancer
Authors: Thangavel Chellappagounder , Boopathi Ettickan , Liu Yi , McNair Christopher , Haber Alex , Perepelyuk Maryna , Bhardwaj Anshul , Addya Sankar , Ertel Adam , Shoyele Sunday , Birbe Ruth , Salvino Joseph M. , Dicker Adam P. , Knudsen Karen E. , Den Robert B.
Published: April 2023

Supplemental Table 2
Supplementary Figure 1 from Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib
Authors: Rothenberg S. Michael , McFadden David G. , Palmer Edwin L. , Daniels Gilbert H. , Wirth Lori J.
Published: April 2023

Supplementary Figure 1. Patients with new iodine uptake after four weeks of dabrafenib.
Supplementary Figures from Wide Variability in the Time Required for Immunotoxins to Kill B Lineage Acute Lymphoblastic Leukemia Cells: Implications for Trial Design
Authors: Müller Fabian , Cunningham Tyler , Liu Xiu Fen , Wayne Alan S. , Pastan Ira
Published: April 2023

Figure S1. KOPN-8 from murine BM has similar levels of CD22 and RIT sensitivity as in cell culture Figure S2. LMB-11-Alexa 647 in KOPN-8 from murine BM reaches maximal signal intensity after only 1 h circulation time Figure S3. Compared to the most active rIT HA22, introduction of every new variable in LMB-11 reduced activity and increased exposure time against KOPN-8.
supplementary figure 3 from Preclinical Assessment of Efficacy of Radiation Dose Painting Based on Intratumoral FDG-PET Uptake
Authors: Trani Daniela , Yaromina Ala , Dubois Ludwig , Granzier Marlies , Peeters Sarah G.J.A. , Biemans Rianne , Nalbantov Georgi , Lieuwes Natasja , Reniers Brigitte , Troost Esther E.G.C. , Verhaegen Frank , Lambin Philippe
Published: April 2023

Time to reach 2-times starting tumor volume (TGTV2) increases linearly with increasing uniform radiation dose.
Supplementary Figure 7 from Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma
Authors: Pham Christina D. , Flores Catherine , Yang Changlin , Pinheiro Elaine M. , Yearley Jennifer H. , Sayour Elias J. , Pei Yanxin , Moore Colin , McLendon Roger E. , Huang Jianping , Sampson John H. , Wechsler-Reya Robert , Mitchell Duane A.
Published: April 2023

Confirmation of calculation strategy of evaluating immune infiltration between two MB subtypes via staining of different APC markers. Same differential expression in Ptch1 tumor model observed.
Supplementary Figure 5 from Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma
Authors: Pham Christina D. , Flores Catherine , Yang Changlin , Pinheiro Elaine M. , Yearley Jennifer H. , Sayour Elias J. , Pei Yanxin , Moore Colin , McLendon Roger E. , Huang Jianping , Sampson John H. , Wechsler-Reya Robert , Mitchell Duane A.
Published: April 2023

Gating strategy for NSC MB Tumors.
Supplementary Figure 3 from Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma
Authors: Pham Christina D. , Flores Catherine , Yang Changlin , Pinheiro Elaine M. , Yearley Jennifer H. , Sayour Elias J. , Pei Yanxin , Moore Colin , McLendon Roger E. , Huang Jianping , Sampson John H. , Wechsler-Reya Robert , Mitchell Duane A.
Published: April 2023

T cell infiltration within the Ptch1 MB tumor microenvironment correlates with DC infiltration.
Supplementary Table 2 from Topical Application of a Mucoadhesive Freeze-Dried Black Raspberry Gel Induces Clinical and Histologic Regression and Reduces Loss of Heterozygosity Events in Premalignant Oral Intraepithelial Lesions: Results from a Multicentered, Placebo-Controlled Clinical Trial
Authors: Mallery Susan R. , Tong Meng , Shumway Brian S. , Curran Alice E. , Larsen Peter E. , Ness Gregory M. , Kennedy Kelly S. , Blakey George H. , Kushner George M. , Vickers Aaron M. , Han Brian , Pei Ping , Stoner Gary D.
Published: April 2023

PDF file - 63KB, Long term follow up of clinical trial patients.
Supplementary Video from Multimodal Image-Guided Surgical and Photodynamic Interventions in Head and Neck Cancer: From Primary Tumor to Metastatic Drainage
Authors: Muhanna Nidal , Cui Liyang , Chan Harley , Burgess Laura , Jin Cheng S. , MacDonald Thomas D. , Huynh Elizabeth , Wang Fan , Chen Juan , Irish Jonathan C. , Zheng Gang
Published: April 2023

PET imaging of HNC with PLP
Supplemental Figure S2 from 18F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
Authors: Chang Edwin , Liu Hongguang , Unterschemmann Kerstin , Ellinghaus Peter , Liu Shuanglong , Gekeler Volker , Cheng Zhen , Berndorff Dietmar , Gambhir Sanjiv S.
Published: April 2023

Supplemental Figure S2. Dose-dependent effect of BAY 87-243 on (A) 18F-FAZA uptake and (B) tumor volume for PC3 xenografts of nude, murine models.
Supplementary Figure Legends from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice
Authors: Kim Sun-Jin , Lee Ho Jeong , Kim Mark Seungwook , Choi Hyun Jin , He Junqin , Wu Qiuyu , Aldape Kenneth , Weinberg Jeffrey S. , Yung W.K. Alfred , Conrad Charles A. , Langley Robert R. , Lehembre François , Regenass Urs , Fidler Isaiah J.
Published: April 2023

Legends to Supplementary Figures 1-6
Supplemental figure 2 from Vaccine-Induced Tumor Necrosis Factor–Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
Authors: van der Sluis Tetje C. , van Duikeren Suzanne , Huppelschoten Suzanna , Jordanova Ekaterina S. , Beyranvand Nejad Elham , Sloots Arjen , Boon Louis , Smit Vincent T.H.B.M. , Welters Marij J.P. , Ossendorp Ferry , van de Water Bob , Arens Ramon , van der Burg Sjoerd H. , Melief Cornelis J.M.
Published: April 2023

Supplemental figure 2) Activation markers on T cells are not affected by cisplatin treatment.
Supplementary Figure 4 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice
Authors: Kim Sun-Jin , Lee Ho Jeong , Kim Mark Seungwook , Choi Hyun Jin , He Junqin , Wu Qiuyu , Aldape Kenneth , Weinberg Jeffrey S. , Yung W.K. Alfred , Conrad Charles A. , Langley Robert R. , Lehembre François , Regenass Urs , Fidler Isaiah J.
Published: April 2023

Supplementary Figure 4. Macitentan suppresses activation of AKT and MAPK signaling pathways on glioma cells and tumor-associated endothelial cells in TMZresistant D54Res glioblastomas.
Supplemental Video 4 from Vaccine-Induced Tumor Necrosis Factor–Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
Authors: van der Sluis Tetje C. , van Duikeren Suzanne , Huppelschoten Suzanna , Jordanova Ekaterina S. , Beyranvand Nejad Elham , Sloots Arjen , Boon Louis , Smit Vincent T.H.B.M. , Welters Marij J.P. , Ossendorp Ferry , van de Water Bob , Arens Ramon , van der Burg Sjoerd H. , Melief Cornelis J.M.
Published: April 2023

Supplemental Video 4. TC-1 cells were in vitro cultured and treated with cisplatin (2 ÃŽÂ¼g/ml) and TNFÃŽÂ± (250iU). Cell death was followed for 22 hours using Annexin-V staining and automated imaging on a BD pathway 855 imager. Every hour a picture was taken.
Supplemental Video 3 from Vaccine-Induced Tumor Necrosis Factor–Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
Authors: van der Sluis Tetje C. , van Duikeren Suzanne , Huppelschoten Suzanna , Jordanova Ekaterina S. , Beyranvand Nejad Elham , Sloots Arjen , Boon Louis , Smit Vincent T.H.B.M. , Welters Marij J.P. , Ossendorp Ferry , van de Water Bob , Arens Ramon , van der Burg Sjoerd H. , Melief Cornelis J.M.
Published: April 2023

Supplemental Video 3. TC-1 cells were in vitro cultured wer treated with TNFÃŽÂ± (250iU). Cell death was followed for 22 hours using Annexin-V staining and automated imaging on a BD pathway 855 imager. Every hour a picture was taken.
Supplemental Video 1 from Vaccine-Induced Tumor Necrosis Factor–Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death
Authors: van der Sluis Tetje C. , van Duikeren Suzanne , Huppelschoten Suzanna , Jordanova Ekaterina S. , Beyranvand Nejad Elham , Sloots Arjen , Boon Louis , Smit Vincent T.H.B.M. , Welters Marij J.P. , Ossendorp Ferry , van de Water Bob , Arens Ramon , van der Burg Sjoerd H. , Melief Cornelis J.M.
Published: April 2023

Supplemental Video 1. TC-1 cells were in vitro cultured and left untreated.Cell death was followed for 22 hours using Annexin-V staining and automated imaging on a BD pathway 855 imager. Every hour a picture was taken.
Supplementary Table Set S30-S35 from Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
Authors: Burstein Matthew D. , Tsimelzon Anna , Poage Graham M. , Covington Kyle R. , Contreras Alejandro , Fuqua Suzanne A.W. , Savage Michelle I , Osborne C. Kent , Hilsenbeck Susan G. , Chang Jenny C. , Mills Gordon B. , Lau Ching C. , Brown Powel H.
Published: April 2023

Table S30. GISTIC 2.0 Significant Regions for All TNBC Cases Table S31. GISTIC 2.0 Significant Regions for All Subtype 1 (LAR) Cases. Table S32. GISTIC 2.0 Significant Regions for All Subtype 2 (MES) Cases. Table S33. GISTIC 2.0 Significant Regions for All Subtype 3 (BLIS) Cases. Table S34. GISTIC 2.0 Significant Regions for All Subtype 4 (BLIA) Cases. Table S35. Correlations of Gene mRNA with GISTIC 2.0 DNA Regions for All TNBC Cases.
Supplementary Table Set S23-S24 from Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
Authors: Burstein Matthew D. , Tsimelzon Anna , Poage Graham M. , Covington Kyle R. , Contreras Alejandro , Fuqua Suzanne A.W. , Savage Michelle I , Osborne C. Kent , Hilsenbeck Susan G. , Chang Jenny C. , Mills Gordon B. , Lau Ching C. , Brown Powel H.
Published: April 2023

Table S23. CoxPH Models for Sabatier Set Table S24. CoxPH Models for Curtis Set
Supplemental Table 3 from An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors
Authors: Bikos Vasilis , Karypidou Maria , Stalika Evangelia , Baliakas Panagiotis , Xochelli Aliki , Sutton Lesley-Ann , Papadopoulos George , Agathangelidis Andreas , Papadopoulou Evdoxia , Davis Zadie , Algara Patricia , Kanellis George , Traverse-Glehen Alexandra , Mollejo Manuela , Anagnostopoulos Achilles , Ponzoni Maurilio , Gonzalez David , Pospisilova Sarka , Matutes Estella , Piris Miguel Angel , Papadaki Theodora , Ghia Paolo , Rosenquist Richard , Oscier David , Darzentas Nikos , Tzovaras Dimitrios , Belessi Chrysoula , Hadzidimitriou Anastasia , Stamatopoulos Kostas
Published: April 2023

IGK/L rearrangements'intraclonal diversification characteristics. Counts, distribution, hotspot targeting of confirmed/unconfirmed mutations and respective amino acid changes across gene groups and IGLV subregions.
Supplemental Table from Sequential Intravesical Mitomycin plus Bacillus Calmette–Guérin for Non–Muscle-Invasive Urothelial Bladder Carcinoma: Translational and Phase I Clinical Trial
Authors: Svatek Robert S. , Zhao Xiang Ru. , Morales Edwin E. , Jha Mithilesh K. , Tseng Timothy Y. , Hugen Cory M. , Hurez Vincent , Hernandez Javier , Curiel Tyler J.
Published: April 2023

Supplemental Table. Number (percent) of patients experiencing symptoms by week of therapy
Supplementary Methods, Supplementary Tables 1-5, Supplementary Figures 1-11, Supplementary References from Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML
Authors: Sadovnik Irina , Hoelbl-Kovacic Andrea , Herrmann Harald , Eisenwort Gregor , Cerny-Reiterer Sabine , Warsch Wolfgang , Hoermann Gregor , Greiner Georg , Blatt Katharina , Peter Barbara , Stefanzl Gabriele , Berger Daniela , Bilban Martin , Herndlhofer Susanne , Sill Heinz , Sperr Wolfgang R. , Streubel Berthold , Mannhalter Christine , Holyoake Tessa L. , Sexl Veronika , Valent Peter
Published: April 2023

Tables: S1 Specification of monoclonal antibodies (mAb) used in this study; S2 PatientsÂ´ characteristics - chronic myeloid leukemia (CML); S3 PatientsÂ´ characteristics - ormal/reactive BM; S4 Detection of BCR/ABL1 in sorted CML cells by FISH; S5 Major genes up-regulated by gene array analysis on KU812 cells transduced with a CD25 shRNA (KU812 CD25 shRNA, clone #2) compared to KU812 cells transduced with a random control shRNA (KU812 RDM shRNA); Figures: S1 CML LSCs co-express CD25 together with other stem cell markers; S2 Expression of BCR/ABL1 in CD34+/CD38âˆ’/CD25+ stem cells obtained from a patient with CML as determined by fluorescence in situ hybridization (FISH); S3 Clonogenic growth of CML LSCs and normal stem cells obtained from two patients with Ph+ CML; S4 Western blotting confirmed the knock-down of STAT5 in KU812 cells; S5 Drug-induced upregulation of CD25 in CML cell lines; S6 Effects of imatinib on CD25 surface expression in Ba/F3 cells expressing diverse BCR/ABL1 mutants; S7 Effects of interleukin-2 (IL-2) on growth of untreated and BEZ235-treated CML cells; S8 Effect of transduced CD25 on growth of CML cells lines; S9 Pathway analysis of KU812 cells transduced with a CD25 shRNA; S10 Effects of shRNA-induced knock-down of CD25 on cell cycle progression and apoptosis in KU812 cells; S11 Effects of shRNA-induced knock-down of CD25 on the responsiveness of KU812 cells to imatinib, nilotinib, ponatinib and BEZ235.
Supplementary Table 3 from Triple-Negative versus Non–Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study
Authors: Podo Franca , Santoro Filippo , Di Leo Giovanni , Manoukian Siranoush , de Giacomi Clelia , Corcione Stefano , Cortesi Laura , Carbonaro Luca A. , Trimboli Rubina M. , Cilotti Anna , Preda Lorenzo , Bonanni Bernardo , Pensabene Matilde , Martincich Laura , Savarese Antonella , Contegiacomo Alma , Sardanelli Francesco
Published: April 2023

Patterns of recurrence in triple negative breast cancer (TNBC) and non-TNBC patients
Supplementary Table 2 from Triple-Negative versus Non–Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study
Authors: Podo Franca , Santoro Filippo , Di Leo Giovanni , Manoukian Siranoush , de Giacomi Clelia , Corcione Stefano , Cortesi Laura , Carbonaro Luca A. , Trimboli Rubina M. , Cilotti Anna , Preda Lorenzo , Bonanni Bernardo , Pensabene Matilde , Martincich Laura , Savarese Antonella , Contegiacomo Alma , Sardanelli Francesco
Published: April 2023

Characteristics of the three interval cancers observed during the study
Supplementary Table S1 from Recurrent PRDM10 Gene Fusions in Undifferentiated Pleomorphic Sarcoma
Authors: Hofvander Jakob , Tayebwa Johnbosco , Nilsson Jenny , Magnusson Linda , Brosjö Otte , Larsson Olle , Vult von Steyern Fredrik , Mandahl Nils , Fletcher Christopher D.M. , Mertens Fredrik
Published: April 2023

Supplementary Table S1. Clinical, morphologic, and genetic data on the patient cohort
Supplementary figure legend from Autocrine Activation of CHRM3 Promotes Prostate Cancer Growth and Castration Resistance via CaM/CaMKK–Mediated Phosphorylation of Akt
Authors: Wang Naitao , Yao Ming , Xu Jin , Quan Yizhou , Zhang Kaiqing , Yang Ru , Gao Wei-Qiang
Published: April 2023

Supplementary figure legend
Supplementary Table S1 from Autocrine Activation of CHRM3 Promotes Prostate Cancer Growth and Castration Resistance via CaM/CaMKK–Mediated Phosphorylation of Akt
Authors: Wang Naitao , Yao Ming , Xu Jin , Quan Yizhou , Zhang Kaiqing , Yang Ru , Gao Wei-Qiang
Published: April 2023

Supplementary Table S1. The sequences of forward and reverse primers used in this study
Supplementary Figure Legends from Toll-like Receptor Agonist Imiquimod Facilitates Antigen-Specific CD8+ T-cell Accumulation in the Genital Tract Leading to Tumor Control through IFNγ
Authors: Soong Ruey-Shyang , Song Liwen , Trieu Janson , Knoff Jayne , He Liangmei , Tsai Ya-Chea , Huh Warner , Chang Yung-Nien , Cheng Wen-Fang , Roden Richard B.S. , Wu T.-C. , Trimble Cornelia L. , Hung Chien-Fu
Published: April 2023

PDF file - 71K
Supplementary Methods, Figures 1-3, Table 1 from Preclinical Efficacy and Safety Assessment of an Antibody–Drug Conjugate Targeting the c-RET Proto-Oncogene for Breast Carcinoma
Authors: Nguyen Minh , Miyakawa Shuichi , Kato Junichi , Mori Toshiyuki , Arai Toshimitsu , Armanini Mark , Gelmon Karen , Yerushalmi Rinat , Leung Samuel , Gao Dongxia , Landes Gregory , Haak-Frendscho Mary , Elias Kathleen , Simmons Andrew D.
Published: April 2023

Supplementary Methods, Figures 1-3, Table 1. Supplementary Table S1. Cytotoxicity assessment of maytansine conjugates in RET-positive cell lines (IC50 {plus minus} SE [nM]); Supplementary Figure S1. Breast cancer patient survival was stratified based on RET expression by immunohistochemistry; Figure S2. In vitro investigation of Y078-DM4 bystander activity. Figure S3. ADCs elicit dose-dependent, reversible DM1-mediated alterations in clinical chemistry.
Supplementary Video 2 from Immunotherapy Targeting Folate Receptor Induces Cell Death Associated with Autophagy in Ovarian Cancer
Authors: Wen Yunfei , Graybill Whitney S. , Previs Rebecca A. , Hu Wei , Ivan Cristina , Mangala Lingegowda S. , Zand Behrouz , Nick Alpa M. , Jennings Nicholas B. , Dalton Heather J. , Sehgal Vasudha , Ram Prahlad , Lee Ju-Seog , Vivas-Mejia Pablo E. , Coleman Robert L. , Sood Anil K.
Published: April 2023

Supplementary Video 2. 3-D SKOV3ip1 spheroids expressing pGFP-RFP-LC3 were treated with MORAB-003
Supplementary Table 9 from DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas
Authors: Malouf Gabriel G. , Su Xiaoping , Zhang Jianping , Creighton Chad J. , Ho Thai H. , Lu Yue , Raynal Noël J.-M. , Karam Jose A. , Tamboli Pheroze , Allanick Frederick , Mouawad Roger , Spano Jean-Philippe , Khayat David , Wood Christopher G. , Jelinek Jaroslav , Tannir Nizar M.
Published: April 2023

Raw data for β-values of probe sets related to our 56 genes signature in an independent dataset encompassing 4 normal kidneys and 37 renal cell carcinomas belonging to diverse histopathological subtypes.
Figure S2 from DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas
Authors: Malouf Gabriel G. , Su Xiaoping , Zhang Jianping , Creighton Chad J. , Ho Thai H. , Lu Yue , Raynal Noël J.-M. , Karam Jose A. , Tamboli Pheroze , Allanick Frederick , Mouawad Roger , Spano Jean-Philippe , Khayat David , Wood Christopher G. , Jelinek Jaroslav , Tannir Nizar M.
Published: April 2023

Unsupervised clustering of DNA methylation using 56 genes epi-signature in an independent data set encompassing 37 renal cell carcinomas cases. C2 contains the majority of oncocytoma and chromophobe RCC cases (n=11/13) as compared to C1 which encompasses the remaining RCC subtypes including clear-cell RCC (ccRCC) , papillary RCC (pRCC) and translocation RCC (tRCC).
Supplemental Figure 4 from AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma
Authors: Doñate Fernando , Raitano Arthur , Morrison Kendall , An Zili , Capo Linnette , Aviña Hector , Karki Sher , Morrison Karen , Yang Peng , Ou Jimmy , Moriya Ryuichi , Shostak Yuriy , Malik Faisal , Nadell Rossana , Liu Wendy , Satpayev Daulet , Atkinson John , Joseph Ingrid B.J. , Pereira Daniel S. , Challita-Eid Pia M. , Stover David R.
Published: April 2023

Supplemental Figure 4. Pharmacokinetics of AGS16F. Mice were injected with a single dose of AGS16F.
Supplemental Figure 1 from A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report
Authors: Fouladi Maryam , Perentesis John P. , Wagner Lars M. , Vinks Alexander A. , Reid Joel M. , Ahern Charlotte , Thomas George , Mercer Carol A. , Krueger Darcy A. , Houghton Peter J. , Doyle L. Austin , Chen Helen , Weigel Brenda , Blaney Susan M.
Published: April 2023

Supplemental Figure 1. Graph of IMC-A12 trough serum concentrations versus time.
Supplemental Table S2 from DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia
Authors: Sehgal Alison R. , Gimotty Phyllis A. , Zhao Jianhua , Hsu Jing-Mei , Daber Robert , Morrissette Jennifer D. , Luger Selina , Loren Alison W. , Carroll Martin
Published: April 2023

Supplemental Table S2. Treatment stratified by DNMT3A status
Supplemental Table S1 from DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia
Authors: Sehgal Alison R. , Gimotty Phyllis A. , Zhao Jianhua , Hsu Jing-Mei , Daber Robert , Morrissette Jennifer D. , Luger Selina , Loren Alison W. , Carroll Martin
Published: April 2023

Supplemental Table S1. Frequency of DNMT3A mutations
Supplemental Table 4. from NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem–Like Cells in Adenoid Cystic Carcinoma
Authors: Panaccione Alex , Chang Michael T. , Carbone Beatrice E. , Guo Yan , Moskaluk Christopher A. , Virk Renu K. , Chiriboga Luis , Prasad Manju L. , Judson Benjamin , Mehra Saral , Yarbrough Wendell G. , Ivanov Sergey V.
Published: April 2023

Genes and pathways suppressed by FABP7 knockdown in Accx11 cells.
Table S3 from Complete Loss of PTEN Protein Expression Correlates with Shorter Time to Brain Metastasis and Survival in Stage IIIB/C Melanoma Patients with BRAFV600 Mutations
Authors: Bucheit Amanda D. , Chen Guo , Siroy Alan , Tetzlaff Michael , Broaddus Russell , Milton Denai , Fox Patricia , Bassett Roland , Hwu Patrick , Gershenwald Jeffrey E. , Lazar Alexander J. , Davies Michael A.
Published: April 2023

Table S3. Clinical outcomes by PTEN status in patients with BRAF V600 mutations
Table S2 from Complete Loss of PTEN Protein Expression Correlates with Shorter Time to Brain Metastasis and Survival in Stage IIIB/C Melanoma Patients with BRAFV600 Mutations
Authors: Bucheit Amanda D. , Chen Guo , Siroy Alan , Tetzlaff Michael , Broaddus Russell , Milton Denai , Fox Patricia , Bassett Roland , Hwu Patrick , Gershenwald Jeffrey E. , Lazar Alexander J. , Davies Michael A.
Published: April 2023

Table S2. Multivariate analysis of overall survival and time to CNS metastasis in all stage IIIB/C melanoma patients
Supplemental Table 2. from NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem–Like Cells in Adenoid Cystic Carcinoma
Authors: Panaccione Alex , Chang Michael T. , Carbone Beatrice E. , Guo Yan , Moskaluk Christopher A. , Virk Renu K. , Chiriboga Luis , Prasad Manju L. , Judson Benjamin , Mehra Saral , Yarbrough Wendell G. , Ivanov Sergey V.
Published: April 2023

Quantitative RT-PCR analysis of differential gene expression in CD133+ and CD133- Accx11 cells.
Table S1 from Complete Loss of PTEN Protein Expression Correlates with Shorter Time to Brain Metastasis and Survival in Stage IIIB/C Melanoma Patients with BRAFV600 Mutations
Authors: Bucheit Amanda D. , Chen Guo , Siroy Alan , Tetzlaff Michael , Broaddus Russell , Milton Denai , Fox Patricia , Bassett Roland , Hwu Patrick , Gershenwald Jeffrey E. , Lazar Alexander J. , Davies Michael A.
Published: April 2023

Table S1. Demographics, tumor characteristics, and clinical outcomes by tumor mutation status
Supplemental Figure 5. from NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem–Like Cells in Adenoid Cystic Carcinoma
Authors: Panaccione Alex , Chang Michael T. , Carbone Beatrice E. , Guo Yan , Moskaluk Christopher A. , Virk Renu K. , Chiriboga Luis , Prasad Manju L. , Judson Benjamin , Mehra Saral , Yarbrough Wendell G. , Ivanov Sergey V.
Published: April 2023

Tumors formed from injected Accx11 CD133- cells closely parallel tumors formed from injected CD133+ cells with respect to histological grade by H&E staining (A), gene expression by qRT-PCR (B), and protein expression by immunoblot (C). β-actin serves as a control for all experiments. Error bars represent standard error representative of at least two experiments.
Supplemental Table 1 from CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment
Authors: DeMichele Angela , Clark Amy S. , Tan Kay See , Heitjan Daniel F. , Gramlich Kristi , Gallagher Maryann , Lal Priti , Feldman Michael , Zhang Paul , Colameco Christopher , Lewis David , Langer Melissa , Goodman Noah , Domchek Susan , Gogineni Keerthi , Rosen Mark , Fox Kevin , O'Dwyer Peter
Published: April 2023

Supplemental Table 1. Biomarker Associations with Outcome
Supplementary Figure Legend from Curing Mice with Large Tumors by Locally Delivering Combinations of Immunomodulatory Antibodies
Authors: Dai Min , Yip Yuen Yee , Hellstrom Ingegerd , Hellstrom Karl Erik
Published: April 2023

Figure legends for four supplementary figures.
Supplementary Figure and Table Legends from Defects in the Fanconi Anemia Pathway in Head and Neck Cancer Cells Stimulate Tumor Cell Invasion through DNA-PK and Rac1 Signaling
Authors: Romick-Rosendale Lindsey E. , Hoskins Elizabeth E. , Privette Vinnedge Lisa M. , Foglesong Grant D. , Brusadelli Marion G. , Potter S. Steven , Komurov Kakajan , Brugmann Samantha A. , Lambert Paul F. , Kimple Randall J. , Virts Elizabeth L. , Hanenberg Helmut , Gillison Maura L. , Wells Susanne I.
Published: April 2023

Legends
Supplemental Tables and Figures from Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer
Authors: Peeters Marc , Oliner Kelly S. , Price Timothy J. , Cervantes Andrés , Sobrero Alberto F. , Ducreux Michel , Hotko Yevhen , André Thierry , Chan Emily , Lordick Florian , Punt Cornelis J.A. , Strickland Andrew H. , Wilson Gregory , Ciuleanu Tudor E. , Roman Laslo , Van Cutsem Eric , He Pei , Yu Hua , Koukakis Reija , Terwey Jan-Henrik , Jung Andre S. , Sidhu Roger , Patterson Scott D.
Published: April 2023

Contains: Table S1. RAS and BRAF Mutation Status Table S2. Objective Response Rate in Patients with Mutated RAS Table S3. Depth of Response and Early Tumor Response in Wild-type KRAS Exon 2 Patients Figure S1. Disposition of patients in the study and RAS ascertainment.
Supplemental table 1 from Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations
Authors: Wang Kai , Russell Jeffery S. , McDermott Jessica D. , Elvin Julia A. , Khaira Depinder , Johnson Adrienne , Jennings Timothy A. , Ali Siraj M. , Murray Molly , Marshall Carrie , Oldham Dwight S. , Washburn Donna , Wong Stuart J. , Chmielecki Juliann , Yelensky Roman , Lipson Doron , Miller Vincent A. , Stephens Philip J. , Serracino Hilary S. , Ross Jeffrey S. , Bowles Daniel W.
Published: April 2023

Detailed genetic results
Supplementary Table 1 from Epigenetic Reprogramming Strategies to Reverse Global Loss of 5-Hydroxymethylcytosine, a Prognostic Factor for Poor Survival in High-grade Serous Ovarian Cancer
Authors: Tucker Douglass W. , Getchell Christopher R. , McCarthy Eric T. , Ohman Anders W. , Sasamoto Naoko , Xu Shuyun , Ko Joo Yeon , Gupta Mamta , Shafrir Amy , Medina Jamie E. , Lee Jonathan J. , MacDonald Lauren A. , Malik Ammara , Hasselblatt Kathleen T , Li Wenjing , Zhang Hong , Kaplan Samuel J. , Murphy George F. , Hirsch Michelle S. , Liu Joyce F. , Matulonis Ursula A. , Terry Kathryn L. , Lian Christine G. , Dinulescu Daniela M.
Published: April 2023

Characteristics of all HGSOC cases included in the BWH TMA
Supplemental Figure S3 from Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo
Authors: Kimbrough Charles W. , Khanal Anil , Zeiderman Matthew , Khanal Bigya R. , Burton Neal C. , McMasters Kelly M. , Vickers Selwyn M. , Grizzle William E. , McNally Lacey R.
Published: April 2023

Supplemental Figure S3: Elliptical 3.5 mm2 ROIs were drawn based upon anatomical location and this size was maintained for relative quantitation of signal accumulation in the pancreas tumor, kidney, and liver. Because the liver and kidney are more easily identified in separate slices, two slices are shown which also contain the pancreas tumor. The location of orthotopic tumors was identified based upon the presence of deoxy-hemoglobin and relative location of the spleen and kidney as indicated by a yellow ellipse (A-B). Due to the location of the pancreas tumor and to prevent errors in organ identification, elliptical 3.5 mm2 ROIs were also drawn in the (A) uninvolved liver (red ellipse) and (B) opposite kidney (white ellipse). The 3.5 mm2 ellipse size was maintained among all ROIs in all mice and for all organs, but ROIs were rotated as needed based upon deoxy-hemoglobin localization to ensure that the probe accumulation within the pancreas tumors as accurate.
Supplementary Table 2 from Direct Serum Assay for Cell-Free Bmi-1 mRNA and Its Potential Diagnostic and Prognostic Value for Colorectal Cancer
Authors: Zhang Xin , Yang Xiaoyun , Zhang Yanli , Liu Xinfeng , Zheng Guixi , Yang Yongmei , Wang Lili , Du Lutao , Wang Chuanxin
Published: April 2023

Supplementary Table 2. Variability between RT-qPCR and RT-qPCR-D
Supplementary Table 1 from Anti-CCR4 Monoclonal Antibody Mogamulizumab for the Treatment of EBV-Associated T- and NK-Cell Lymphoproliferative Diseases
Authors: Kanazawa Tetsuhiro , Hiramatsu Yutaka , Iwata Seiko , Siddiquey Mohammed , Sato Yoshitaka , Suzuki Michio , Ito Yoshinori , Goshima Fumi , Murata Takayuki , Kimura Hiroshi
Published: April 2023

Summary of patients with EBV-associated lymphoproliferative diseases and CCR4 expression.
Supplementary figure legends from RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer
Authors: Liu Yajing , Burness Monika L. , Martin-Trevino Rachel , Guy Joey , Bai Shoumin , Harouaka Ramdane , Brooks Michael D. , Shang Li , Fox Alex , Luther Tahra K. , Davis April , Baker Trenton L. , Colacino Justin , Clouthier Shawn G. , Shao Zhi-ming , Wicha Max S. , Liu Suling
Published: April 2023

Supplementary figures 1-8 legends
Supplementary Table S1-2 from The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma
Authors: Zhang Hai-Feng , Chen Ye , Wu Chengsheng , Wu Zhi-Yong , Tweardy David J. , Alshareef Abdulraheem , Liao Lian-Di , Xue Yu-Jie , Wu Jian-Yi , Chen Bo , Xu Xiu-E , Gopal Keshav , Gupta Nidhi , Li En-Min , Xu Li-Yan , Lai Raymond
Published: April 2023

Supplementary Table S1. Characteristics of the ESCC patients (n=286). Supplementary Table S2. Correlation among clinicopathological parameters and the expression of STAT3β in ESCC patients (n=286).
Supplementary Figure S1 from Patient-Derived Xenografts from Non–Small Cell Lung Cancer Brain Metastases Are Valuable Translational Platforms for the Development of Personalized Targeted Therapy
Authors: Lee Hye Won , Lee Jung-il , Lee Se Jeong , Cho Hyun Jung , Song Hye Jin , Jeong Da Eun , Seo Yun Jee , Shin Sang , Joung Je-Gun , Kwon Yong-Jun , Choi Yoon-La , Park Woong-Yang , Lee Hyun Moo , Seol Ho Jun , Shim Young Mog , Joo Kyeung Min , Nam Do-Hyun
Published: April 2023

Supplementary Figure S1. Histopathology of NSCLC brain metastases and their corresponding PDXs. Histological subtype and differentiation status was indicated for each case. ADC = adenocarcinoma, LCC = large cell carcinoma, SQCC = squamous cell carcinoma.
Supplementary Table 1 from Relationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer
Authors: Hatzis Christos , Symmans W. Fraser , Zhang Ya , Gould Rebekah E. , Moulder Stacy L. , Hunt Kelly K. , Abu-Khalaf Maysa , Hofstatter Erin W. , Lannin Donald , Chagpar Anees B. , Pusztai Lajos
Published: April 2023

Patient Characteristics
Supplementary Figure Legend from Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors
Authors: Patnaik Amita , Weiss Glen J. , Leonard John E. , Rasco Drew Warren , Sachdev Jasgit C. , Fisher Terrence L. , Winter Laurie A. , Reilly Christine , Parker Robert B. , Mutz Danielle , Blaydorn Lisa , Tolcher Anthony W. , Zauderer Maurice , Ramanathan Ramesh K.
Published: April 2023

This supplementary information file contains the Figure Legend for the Supplementary Figure S1. This figure legend and Supplementary Figure Fig S1 are intended for publication with the manuscript; Fig S1 shows the effect of VX15/2503 administration on serum levels of soluble SEMA4D. Article text related to Fig S1 is contained in the Results and Discussion sections, pages 19 and 22, respectively.
Supplementary Data from The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4
Authors: Liu Li , Mayes Patrick A. , Eastman Stephen , Shi Hong , Yadavilli Sapna , Zhang Tianqian , Yang Jingsong , Seestaller-Wehr Laura , Zhang Shu-Yun , Hopson Chris , Tsvetkov Lyuben , Jing Junping , Zhang Shu , Smothers James , Hoos Axel
Published: April 2023

Supplementary Materials and Methods
Table 1 from Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy
Authors: Smyth Elizabeth , Zhang Shenli , Cunningham David , Wotherspoon Andrew , Soong Richie , Peckitt Clare , Valeri Nicola , Fassan Matteo , Rugge Massimo , Okines Alicia , Allum William , Stenning Sally , Nankivell Matthew , Langley Ruth , Tan Patrick
Published: April 2023

Association between genotype and toxicity Grade 3 or greater
Supplementary Table S2 from Gas6/AXL Signaling Regulates Self-Renewal of Chronic Myelogenous Leukemia Stem Cells by Stabilizing β-Catenin
Authors: Jin Yanli , Nie Danian , Li Juan , Du Xin , Lu Yuhong , Li Yangqiu , Liu Chang , Zhou Jingfeng , Pan Jingxuan
Published: April 2023

PCR Primers
Supplementary Table S1 from Gas6/AXL Signaling Regulates Self-Renewal of Chronic Myelogenous Leukemia Stem Cells by Stabilizing β-Catenin
Authors: Jin Yanli , Nie Danian , Li Juan , Du Xin , Lu Yuhong , Li Yangqiu , Liu Chang , Zhou Jingfeng , Pan Jingxuan
Published: April 2023

CML Patients Information
Supplementary Table S2 from Mutational Analysis of Gene Fusions Predicts Novel MHC Class I–Restricted T-Cell Epitopes and Immune Signatures in a Subset of Prostate Cancer
Authors: Kalina Jennifer L. , Neilson David S. , Lin Yen-Yi , Hamilton Phineas T. , Comber Alexandra P. , Loy Emma M.H. , Sahinalp S. Cenk , Collins Colin C. , Hach Faraz , Lum Julian J.
Published: April 2023

List of patient fusions
supplementary file 2 from Multilayered Omics-Based Analysis of a Head and Neck Cancer Model of Cisplatin Resistance Reveals Intratumoral Heterogeneity and Treatment-Induced Clonal Selection
Authors: Niehr Franziska , Eder Theresa , Pilz Tanja , Konschak Robert , Treue Denise , Klauschen Frederick , Bockmayr Michael , Türkmen Seval , Jöhrens Korinna , Budach Volker , Tinhofer Ingeborg
Published: April 2023

Top-50 features associated with the CDDP-sensitive and -resistant phenotypes
Supplementary table 2 from Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration
Authors: Ock Chan-Young , Keam Bhumsuk , Kim Sehui , Lee Ju-Seog , Kim Miso , Kim Tae Min , Jeon Yoon Kyung , Kim Dong-Wan , Chung Doo Hyun , Heo Dae Seog
Published: April 2023

Supplementary Table 2. Characteristics of the patients in TCGA according to the tumor microenvironment immune type
Suppl. figs from Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody
Authors: Dominguez George A. , Condamine Thomas , Mony Sridevi , Hashimoto Ayumi , Wang Fang , Liu Qin , Forero Andres , Bendell Johanna , Witt Robert , Hockstein Neil , Kumar Prasanna , Gabrilovich Dmitry I.
Published: April 2023

Supplemental Figure 1. Characterization of different populations of cells Supplemental Figure 2. Treatment protocol Supplemental Figure 3. Flow diagram of patients enrolled and samples collected on the trial Supplemental Figure 4. Indicated populations of cells in patients during the treatment Supplemental Figure 5. Number of lymphocyte populations in patients with elevated numbers of PMN-MDSC prior to treatment Supplemental Figure 6. Example of staining of tissues with CD8 and PD1 antibodies. CD8+PD1+ cells are shown by arrows.
Supplementary table 1 from Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration
Authors: Ock Chan-Young , Keam Bhumsuk , Kim Sehui , Lee Ju-Seog , Kim Miso , Kim Tae Min , Jeon Yoon Kyung , Kim Dong-Wan , Chung Doo Hyun , Heo Dae Seog
Published: April 2023

Supplementary Table 1. Clinical information and genomic data of TCGA samples
Supplementary figure legends and the title and notes of supplementary tables from A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer
Authors: Kreuzinger Caroline , Geroldinger Angelika , Smeets Dominiek , Braicu Elena Ioana , Sehouli Jalid , Koller Julia , Wolf Andrea , Darb-Esfahani Silvia , Joehrens Korinna , Vergote Ignace , Vanderstichele Adriaan , Boeckx Bram , Lambrechts Diether , Gabra Hani , Wisman G. Bea A. , Trillsch Fabian , Heinze Georg , Horvat Reinhard , Polterauer Stephan , Berns Els , Theillet Charles , Cacsire Castillo-Tong Dan
Published: April 2023

Supplementary figure legends and the title and notes of supplementary tables
Supplementary Table S4 from A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer
Authors: Kreuzinger Caroline , Geroldinger Angelika , Smeets Dominiek , Braicu Elena Ioana , Sehouli Jalid , Koller Julia , Wolf Andrea , Darb-Esfahani Silvia , Joehrens Korinna , Vergote Ignace , Vanderstichele Adriaan , Boeckx Bram , Lambrechts Diether , Gabra Hani , Wisman G. Bea A. , Trillsch Fabian , Heinze Georg , Horvat Reinhard , Polterauer Stephan , Berns Els , Theillet Charles , Cacsire Castillo-Tong Dan
Published: April 2023

Subgroups of the samples
Figure S2 from Genomic Characterization of Vulvar (Pre)cancers Identifies Distinct Molecular Subtypes with Prognostic Significance
Authors: Nooij Linda S. , ter Haar Natalja T. , Ruano Dina , Rakislova Natalia , van Wezel Tom , Smit Vincent T.H.B.M. , Trimbos Baptist J.B.M.Z. , Ordi Jaume , van Poelgeest Mariette I.E. , Bosse Tjalling
Published: April 2023

Overall survival
Table S1 from Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome
Authors: Derks Jules L. , Leblay Noémie , Thunnissen Erik , van Suylen Robert Jan , den Bakker Michael , Groen Harry J.M. , Smit Egbert F. , Damhuis Ronald , van den Broek Esther C. , Charbrier Amélie , Foll Matthieu , McKay James D. , Fernandez-Cuesta Lynnette , Speel Ernst-Jan M. , Dingemans Anne-Marie C.
Published: April 2023

FISH analysis datafile
Supplementary Table S5 from Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
Authors: Dong Zhong-Yi , Zhong Wen-Zhao , Zhang Xu-Chao , Su Jian , Xie Zhi , Liu Si-Yang , Tu Hai-Yan , Chen Hua-Jun , Sun Yue-Li , Zhou Qing , Yang Jin-Ji , Yang Xue-Ning , Lin Jia-Xin , Yan Hong-Hong , Zhai Hao-Ran , Yan Li-Xu , Liao Ri-Qiang , Wu Si-Pei , Wu Yi-Long
Published: April 2023

Multivariate linear regression analysis of PD-L1 expression in patients stratified by smoking status on the base of TCGA.
Supplementary Table S3 from Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
Authors: Dong Zhong-Yi , Zhong Wen-Zhao , Zhang Xu-Chao , Su Jian , Xie Zhi , Liu Si-Yang , Tu Hai-Yan , Chen Hua-Jun , Sun Yue-Li , Zhou Qing , Yang Jin-Ji , Yang Xue-Ning , Lin Jia-Xin , Yan Hong-Hong , Zhai Hao-Ran , Yan Li-Xu , Liao Ri-Qiang , Wu Si-Pei , Wu Yi-Long
Published: April 2023

Demographics and clinical characteristics of 93 ADC patients according to PD-L1 expression.